Flu Vaccine Manufacturers Increasing Production For Upcoming Season; CDC Directly Buying Millions Of Doses For Distribution To States

Washington Post: CDC and drugmakers boost flu vaccine doses amid fears of an unprecedented respiratory illness season
“Worried about a simultaneous assault of the novel coronavirus and seasonal influenza this winter, public health officials and vaccine manufacturers are making millions of extra flu vaccine doses to protect those most vulnerable to the pandemic and influenza, according to government and company officials. Even though flu season doesn’t begin until the fall, major flu vaccine manufacturers say they plan to boost production by about 10 percent, to about 189 million doses, up from 170 million doses last year, to ensure enough doses exist for an anticipated surge in people seeking flu shots. The Centers for Disease Control and Prevention has taken the rare step of buying 7 million doses directly from manufacturers to be distributed to states for adult vaccination, CDC Director Robert Redfield said in an interview…” (Sun, 6/24).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.